TAF1 Differentially Enhances Androgen Receptor Transcriptional Activity via Its N-Terminal Kinase and Ubiquitin-Activating and -Conjugating Domains

Heinlein, 2004, Androgen receptor in prostate cancer., Endocr Rev, 25, 276, 10.1210/er.2002-0032

Litvinov, 2003, Is the Achilles’ heel for prostate cancer therapy a gain of function in androgen receptor signaling?, J Clin Endocrinol Metab, 88, 2972, 10.1210/jc.2002-022038

Tsai, 1994, Molecular mechanisms of action of steroid/thyroid receptor superfamily members., Annu Rev Biochem, 63, 451, 10.1146/annurev.bi.63.070194.002315

Heinlein, 2002, Androgen receptor (AR) coregulators: an overview., Endocr Rev, 23, 175, 10.1210/edrv.23.2.0460

Horwitz, 1996, Nuclear receptor coactivators and corepressors., Mol Endocrinol, 10, 1167

Fu, 2000, p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation., J Biol Chem, 275, 20853, 10.1074/jbc.M000660200

Gnanapragasam, 2001, Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer., Br J Cancer, 85, 1928, 10.1054/bjoc.2001.2179

Wang, 2001, Identification and characterization of a novel androgen receptor coregulator ARA267-α in prostate cancer cells., J Biol Chem, 276, 40417, 10.1074/jbc.M104765200

Choudhry, 2006, The role of the general transcription factor IIF in androgen receptor-dependent transcription., Mol Endocrinol, 20, 2052, 10.1210/me.2005-0486

Lavery, 2008, Functional characterization of the native NH2-terminal transactivation domain of the human androgen receptor: binding kinetics for interactions with TFIIF and SRC-1a., Biochemistry, 47, 3352, 10.1021/bi702220p

Evans, 1988, The steroid and thyroid hormone receptor superfamily., Science, 240, 889, 10.1126/science.3283939

Roy, 1995, Androgen action., Crit Rev Eukaryot Gene Expr, 5, 157, 10.1615/CritRevEukarGeneExpr.v5.i2.30

Agoulnik, 2006, Androgen receptor action in hormone-dependent and recurrent prostate cancer., J Cell Biochem, 99, 362, 10.1002/jcb.20811

Chang, 1988, Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors., Proc Natl Acad Sci USA, 85, 7211, 10.1073/pnas.85.19.7211

Lubahn, 1988, Cloning of human androgen receptor complementary DNA and localization to the X chromosome., Science, 240, 327, 10.1126/science.3353727

Trapman, 1988, Cloning, structure and expression of a cDNA encoding the human androgen receptor., Biochem Biophys Res Commun, 153, 241, 10.1016/S0006-291X(88)81214-2

Hirst, 2001, A two-hybrid system for transactivator bait proteins., Proc Natl Acad Sci USA, 98, 8726, 10.1073/pnas.141413598

Ray, 2006, Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer., Int J Cancer, 118, 1108, 10.1002/ijc.21469

Wafa, 2003, Isolation and identification of l-dopa decarboxylase as a protein that binds to and enhances transcriptional activity of the androgen receptor using the repressed transactivator yeast two-hybrid system., Biochem J, 375, 373, 10.1042/bj20030689

Albright, 2000, TAFs revisited: more data reveal new twists and confirm old ideas., Gene, 242, 1, 10.1016/S0378-1119(99)00495-3

Martel, 2002, Evidence that TAF-TATA box-binding protein interactions are required for activated transcription in mammalian cells., Mol Cell Biol, 22, 2788, 10.1128/MCB.22.8.2788-2798.2002

Verrijzer, 1996, TAFs mediate transcriptional activation and promoter selectivity., Trends Biochem Sci, 21, 338, 10.1016/0968-0004(96)10044-X

Dikstein, 1996, TAFII250 is a bipartite protein kinase that phosphorylates the base transcription factor RAP74., Cell, 84, 781, 10.1016/S0092-8674(00)81055-7

Mizzen, 1996, The TAFII250 subunit of TFIID has histone acetyltransferase activity., Cell, 87, 1261, 10.1016/S0092-8674(00)81821-8

Pham, 2000, Ubiquitin-activating/conjugating activity of TAFII250, a mediator of activation of gene expression in Drosophila., Science, 289, 2357, 10.1126/science.289.5488.2357

Li, 2004, Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression., Mol Cell, 13, 867, 10.1016/S1097-2765(04)00123-6

Allende-Vega, 2008, Transcription factor TAFII250 phosphorylates the acidic domain of Mdm2 through recruitment of protein kinase CK2., Mol Cell Biochem, 316, 99, 10.1007/s11010-008-9816-3

Lively, 2001, c-Jun binds the N terminus of human TAFII250 to derepress RNA polymerase II transcription in vitro., J Biol Chem, 276, 25582, 10.1074/jbc.M100278200

Léveillard, 1997, The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter., J Biol Chem, 272, 30651, 10.1074/jbc.272.49.30651

Siegert, 2000, Cyclin D1 suppresses retinoblastoma protein-mediated inhibition of TAFII250 kinase activity., Oncogene, 19, 5703, 10.1038/sj.onc.1203966

Cai, 2007, c-Jun has multiple enhancing activities in the novel cross talk between the androgen receptor and Ets variant gene 1 in prostate cancer., Mol Cancer Res, 5, 725, 10.1158/1541-7786.MCR-06-0430

Gaughan, 2005, Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation., Nucleic Acids Res, 33, 13, 10.1093/nar/gki141

Narayanan, 2006, RNA interference-mediated cyclooxygenase-2 inhibition prevents prostate cancer cell growth and induces differentiation: modulation of neuronal protein synaptophysin, cyclin D1, and androgen receptor., Mol Cancer Ther, 5, 1117, 10.1158/1535-7163.MCT-05-0520

Heemers, 2007, Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex., Endocr Rev, 28, 778, 10.1210/er.2007-0019

Wafa

Wafa, 2007, Comprehensive expression analysis of l-dopa decarboxylase and established neuroendocrine markers in neoadjuvant hormone-treated versus varying Gleason grade prostate tumors., Hum Pathol, 38, 161, 10.1016/j.humpath.2006.07.003

Wang, 2002, Functional substitution for TAFII250 by a retroposed homolog that is expressed in human spermatogenesis., Hum Mol Genet, 11, 2341, 10.1093/hmg/11.19.2341

O'Brien, 2000, Different functional domains of TAFII250 modulate expression of distinct subsets of mammalian genes., Proc Natl Acad Sci USA, 97, 2456, 10.1073/pnas.97.6.2456

Read, 2007, Androgen receptor regulation of the versican gene through an androgen response element in the proximal promoter., J Biol Chem, 282, 31954, 10.1074/jbc.M702099200

Miranda, 2007, Regulation of receptors and transporters by ubiquitination: new insights into surprisingly similar mechanisms., Mol Interv, 7, 157, 10.1124/mi.7.3.7

Burgdorf, 2004, TSG101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination., J Biol Chem, 279, 17524, 10.1074/jbc.M313703200

Belz, 2002, In vitro assays to study protein ubiquitination in transcription., Methods, 26, 233, 10.1016/S1046-2023(02)00027-0

Taplin, 2004, Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence., J Cell Biochem, 91, 483, 10.1002/jcb.10653

Chen, 2004, Molecular determinants of resistance to antiandrogen therapy., Nat Med, 10, 33, 10.1038/nm972

Rennie, 1998, Epigenetic mechanisms for progression of prostate cancer., Cancer Metastasis Rev, 17, 401, 10.1023/A:1006121219097

Sirotnak, 2004, Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events., Mol Carcinog, 41, 150, 10.1002/mc.20051

Tilley, 1994, Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis., Cancer Res, 54, 4096

Locke, 2008, Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer., Cancer Res, 68, 6407, 10.1158/0008-5472.CAN-07-5997

Mohler, 2008, A role for the androgen-receptor in clinically localized and advanced prostate cancer., Best Pract Res Clin Endocrinol Metab, 22, 357, 10.1016/j.beem.2008.01.009

Sadar, 1999, Prostate cancer: molecular biology of early progression to androgen independence., Endocr Relat Cancer, 6, 487, 10.1677/erc.0.0060487

Thalmann, 1994, Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer., Cancer Res, 54, 2577

Ueda, 2002, Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells., J Biol Chem, 277, 38087, 10.1074/jbc.M203313200

Culig, 1994, Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor., Cancer Res, 54, 5474

Shang, 2002, Formation of the androgen receptor transcription complex., Mol Cell, 9, 601, 10.1016/S1097-2765(02)00471-9

Nazareth, 1996, Activation of the human androgen receptor through a protein kinase A signaling pathway., J Biol Chem, 271, 19900, 10.1074/jbc.271.33.19900

Sadar, 1999, Androgen-independent induction of prostate- specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways., J Biol Chem, 274, 7777, 10.1074/jbc.274.12.7777

Cheng, 2006, Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression., Cancer Res, 66, 10613, 10.1158/0008-5472.CAN-06-0028

Rodriguez, 1999, SUMO-1 modification activates the transcriptional response of p53., EMBO J, 18, 6455, 10.1093/emboj/18.22.6455

Poukka, 2000, Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1)., Proc Natl Acad Sci USA, 97, 14145, 10.1073/pnas.97.26.14145

Mohler, 2004, The androgen axis in recurrent prostate cancer., Clin Cancer Res, 10, 440, 10.1158/1078-0432.CCR-1146-03

Andrews, 1991, A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells., Nucleic Acids Res, 19, 2499, 10.1093/nar/19.9.2499

Kokubo, 1998, The yeast TAF145 inhibitory domain and TFIIA competitively bind to TATA-binding protein., Mol Cell Biol, 18, 1003, 10.1128/MCB.18.2.1003

Lively, 2004, The basic leucine zipper domain of c-Jun functions in transcriptional activation through interaction with the N terminus of human TATA-binding protein-associated factor-1 (human TAFII250)., J Biol Chem, 279, 26257, 10.1074/jbc.M400892200

Wassarman, 2001, TAFII250: a transcription toolbox., J Cell Sci, 114, 2895, 10.1242/jcs.114.16.2895

Irvin, 2006, Genome-wide transcriptional dependence on TAF1 functional domains., J Biol Chem, 281, 6404, 10.1074/jbc.M513776200

Zhou, 1995, Identification of three proline-directed phosphorylation sites in the human androgen receptor., Mol Endocrinol, 9, 605

Zhu, 2001, Identification of a novel phosphorylation site in human androgen receptor by mass spectrometry., Biochem Biophys Res Commun, 284, 836, 10.1006/bbrc.2001.5030

Lin, 2002, Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells., J Biol Chem, 277, 36570, 10.1074/jbc.M204751200

Xu, 2009, Regulation of androgen receptor transcriptional activity and specificity by RNF6-induced ubiquitination., Cancer Cell, 15, 270, 10.1016/j.ccr.2009.02.021

Kaiser, 2000, Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4., Cell, 102, 303, 10.1016/S0092-8674(00)00036-2

Le Cam, 2006, E4F1 is an atypical ubiquitin ligase that modulates p53 effector functions independently of degradation., Cell, 127, 775, 10.1016/j.cell.2006.09.031